Personalis, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Personalis, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $2.67M, a 5454.17% increase year-over-year.
- Personalis, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $281.00K, a 112.88% increase year-over-year.
- Personalis, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $1.63M, a 1795.35% increase year-over-year.
- Personalis, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $94.00K, a 17.54% decline year-over-year.
- Personalis, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $1.90M, a 852.00% increase from fiscal 2024.
- Personalis, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $200.00K.
- Personalis, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $1.01M, a 51.77% decline from fiscal 2021.
- Personalis, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $2.10M, a 24.85% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $2.67M 10-Q · filed 2026-08-04 | $4.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $281.00K 10-Q · filed 2026-05-07 | $2.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.90M 10-K · filed 2026-02-26 |
| 2025-09-30 | $94.00K 10-Q · filed 2025-11-04 | $360.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $48.00K 10-Q · filed 2026-08-04 | $380.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $132.00K 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $200.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $114.00K 10-Q · filed 2025-11-04 | |
| 2022-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.01M 10-K · filed 2024-02-28 |
| 2022-09-30 | $2.00K 10-Q · filed 2023-11-07 | $1.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $463.00K 10-Q · filed 2023-08-08 | $1.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $516.00K 10-Q · filed 2023-05-03 | $1.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.10M 10-K · filed 2024-02-28 |
| 2021-09-30 | $536.00K 10-Q · filed 2022-11-02 | $2.44M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $466.00K 10-Q · filed 2022-08-03 | $3.17M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $933.00K 10-Q · filed 2022-05-04 | $3.40M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.79M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.28M 10-Q · filed 2021-11-04 | $2.32M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $690.00K 10-Q · filed 2021-08-04 | $1.12M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $323.00K 10-Q · filed 2021-05-05 | $683.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $713.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $68.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $257.00K 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $354.00K 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $99.00K 10-K · filed 2021-02-25 | |
| 2017-12-31 | $76.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |